Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Clinical Nuclear Medicine|June 24, 2003
Repetitive phosphorus-32 peritoneal instillations in a patient with malignant ascitesHans Balink, Edith A Sijmons, Bernard A Zonnenberg, et al.Journal of Palliative Medicine|July 15, 2009
Treatment of painful bone metastases in hormone-refractory prostate cancer with zoledronic acid and samarium-153-ethylenediaminetetramethylphosphonic acid combinedMarnix G E H Lam, John M H de Klerk, Bernard A ZonnenbergJournal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 5, 2014
Natural history and CT scan follow-up of subependymal giant cell tumors in tuberous sclerosis complex patientsMiraude E A P M Adriaensen, Bernard A Zonnenberg, Pim A de JongCurrent Drug Discovery Technologies|November 2, 2010
Targeted radiotherapy of bone malignanciesDavid R Jansen, Gerard C Krijger, Zvonimir I Kolar, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2009
(188)Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity studyMarnix G E H Lam, Tjitske B Bosma, Peter P van Rijk, et al.Case Reports in Dermatology|February 17, 2017
A 28-Year-Old Male Patient with Nail Tumors, Skin Lesions, and EpilepsyDeepak M W Balak, Bernard A Zonnenberg, Juliette M J Spitzer-Naaijkens, et al.Plos One|November 16, 2018
Observational study of characteristics and clinical outcomes of Dutch patients with tuberous sclerosis complex and renal angiomyolipoma treated with everolimusBernard A Zonnenberg, Maureen P Neary, Mei Sheng Duh, et al.Radiology|August 28, 2009
Fatty foci in the myocardium in patients with tuberous sclerosis complex: common finding at CTMiraude E A P M Adriaensen, Cornelia M Schaefer-Prokop, Debbie A C Duyndam, et al.European Urology|December 2, 2008
Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trialNicholas D James, Armelle Caty, Michael Borre, et al.Anti-Cancer Agents in Medicinal Chemistry|July 17, 2007
Radionuclide liver cancer therapies: from concept to current clinical statusMaarten A D Vente, Monique G G Hobbelink, Alfred D van Het Schip, et al.Pageof 7